Brivaracetam
Indication
Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult, adolescents and children from 4 years of age with epilepsy
Amber level 0
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
- Primary care prescribers must be familiar with the drug to take on prescribing responsibility or must get the required information.
- When recommending or handing over care, specialists should ask primary care prescribers to take over prescribing responsibility, and should give enough information about the indication, dose, monitoring requirements, use outside product licence and any necessary dose adjustments to allow them to confidently prescribe.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: